(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

OPERATING SYSTEM OF LIFE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

OPERATING SYSTEM OF LIFE

ST13

US500000079292986

Classe

1, 5, 9, 29, 40, 42

Pedido

79292986

Registro

6982346

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

52

Atualização mais recente

09/01/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 29, 40, 42

Data de depósito

11/05/2020

Data de registro

21/02/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/02/2023

Última transação

09/01/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

GB

Examinador

GRIFFIN, JAMES

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Bit Bio Limited

Representantes

KATRINA G HULL MARKERY LAW LLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 29Classe 40Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media for scientific or research use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical research; all of the foregoing excluding vaccines and RNA-based therapeutics

Classe 5

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; Genetically or otherwise modified cells for medical or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical, therapeutic or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for medical use in drug screening; Cell preparations for genetic testing and screening for medical purposes or clinical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; Tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical or clinical use; Cell separation reagents for medical and clinical use; Dietary supplements; Protein supplements; nutrition supplements

Classe 9

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use; all of the foregoing excluding vaccines and RNA-based therapeutics

Classe 29

Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not live

Classe 40

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, Stem cells for scientific purposes, Stem cells other than for medical or veterinary purposes, Skeletal myocytes for research purposes, Cortical neurons for research purposes, Biological tissue for research and scientific purposes, Biological tissue cultures other than for medical or veterinary purposes, Cultures of cell media other than for medical or veterinary use, Chemical reagents for use in biotechnology, other than for medical or veterinary use, Nutritive agents for processing living cells other than for medical use, Semi-processed natural proteins for manufacturing food, Proteins for use in the manufacture of food products, Proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, Genetically or otherwise modified cells, Cells which are propagated, cultivated and expanded in bioreactors, Cells for the purpose of tissue regeneration, Living cells for medical use, Cells for medical use, Biological preparations for medical use, Diagnostic preparations for medical and/or veterinary purposes, Cell preparations for drug screening, Cell preparations for genetic testing, screening, Stem cells for medical purposes, Stem cells for veterinary purposes, Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, Cell separation reagents, magnetic cell separation equipment, Dietary supplements, Protein supplements, nutrition supplements, Meat, Meat substitutes, Tissue engineered meat, Synthetic meat, Cultured meat, Laboratory-grown meat and Fish, not live; all of the foregoing excluding vaccines and RNA-based therapeutics

Classe 42

Biotechnology research; Scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; Cell separation research services for scientific, research, clinical, therapeutic and manufacturing purposes; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; all of the foregoing excluding vaccines and RNA-based therapeutics

Publicações

Histórico de despachos e eventos da marca no USPTO.

52 publicações encontradas

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/01/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

14/02/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/11/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/05/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/06/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

22/05/2023

FIMP

FINAL DISPOSITION PROCESSED

22/05/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

21/05/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

21/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

21/02/2023

TMBN

TTAB RELEASE CASE TO TRADEMARKS

12/01/2023

OP.T

OPPOSITION TERMINATED NO. 999999

12/01/2023

OP.D

OPPOSITION DISMISSED NO. 999999

12/01/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

11/09/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

24/08/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

24/08/2022

RFNP

REFUSAL PROCESSED BY IB

25/10/2021

OP.I

OPPOSITION INSTITUTED NO. 999999

16/09/2021

OPNS

OPPOSITION NOTICE (IB REFUSAL) SENT TO IB

13/09/2021

OPNC

OPPOSITION NOTICE (IB REFUSAL) CREATED

13/09/2021

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

09/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

18/05/2021

PUBO

PUBLISHED FOR OPPOSITION

18/05/2021

GPNX

NOTIFICATION PROCESSED BY IB

17/05/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

28/04/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

28/04/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

28/04/2021

ISMR

WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST

12/04/2021

ATRV

ATTORNEY REVIEW COMPLETED

09/04/2021

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

09/04/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

23/03/2021

PUBO

PUBLISHED FOR OPPOSITION

23/03/2021

GPNX

NOTIFICATION PROCESSED BY IB

22/03/2021

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

20/03/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/03/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/02/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/02/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/02/2021

LOPR

LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN

05/01/2021

LOPT

LETTER OF PROTEST EVIDENCE FORWARDED

07/12/2020

RFNT

REFUSAL PROCESSED BY IB

19/10/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

30/09/2020

RFRR

REFUSAL PROCESSED BY MPU

30/09/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/09/2020

CNRT

NON-FINAL ACTION WRITTEN

08/09/2020

MAFR

APPLICATION FILING RECEIPT MAILED

08/09/2020

DOCK

ASSIGNED TO EXAMINER

04/09/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/09/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/09/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace OPERATING SYSTEM OF LIFE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.